Filing Details
- Accession Number:
- 0001209191-20-064620
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-21 16:08:01
- Reporting Period:
- 2020-12-18
- Accepted Time:
- 2020-12-21 16:08:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Surgical & Medical Instruments & Apparatus (3841) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1323134 | J Peter Arduini | 1100 Campus Road Princeton NJ 08540 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-18 | 45,000 | $15.79 | 261,713 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-18 | 45,000 | $61.97 | 216,713 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-12-18 | 45,000 | $0.00 | 45,000 | $15.79 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
22,786 | 2021-05-22 | No | 4 | M | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $61.50 to $62.74.
- One-third of the stock options vested on the first anniversary of the grant date which is May 22, 2013 and thereafter with respect to theremaining two-thirds which vested in monthly installments through the 3rd anniversary of the grant date.
- This option was previously reported as covering 32,468 shares at an exercise price of $36.50 per share, but was adjusted pursuant to the antidilutionprovisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.
- In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have beenadjusted to eflect the two-for-one stock split that occurred on December 21, 2016.